Home Pilots Mark Cuban Cost Plus Drug Company partners with PBM EmsanaRx Pilots Mark Cuban Cost Plus Drug Company partners with PBM EmsanaRx By - December 8, 2022 61 0 Facebook Twitter Pinterest WhatsApp The collaboration will offer low-cost medications to employers and employees through a new platform dubbed EmsanaRx Plus. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES DocGo, EmblemHealth partner for patient care after hospitalization Pilots - August 16, 2023 0 Report: Digital health investment is rebounding in 2024 Pilots - July 12, 2024 0 AI firm TIIM Healthcare gets exclusive IP for Duke-NUS sepsis triaging tech Pilots - September 26, 2022 0 PointClickCare acquires value-based care platform Patient Pattern Pilots - March 16, 2023 0 Diagnostic Robotics raises $45M for AI-enabled care management and more digital health fundings Pilots - August 1, 2022 0 POPULAR CATEGORIESPilots2166Applications750Testing283Collaborations15GitHub3